Ligand Pharmaceuticals
Speed Read
0%
300 WPM
-- remaining
Biopharmaceutical company building revenue-generating pharmaceutical assets through partnerships, licensing proprietary drug discovery and development technologies and acquiring royalty rights to marketed and development-stage drugs.